AkzoNobel publishes Q4 and full-year 2013 results

February 6, 2014

  • Q4 volume development positive in all three Business Areas and ROS excluding restructuring costs and incidentals increased, continuing the trend from Q3

  • Revenue for both Q4 and full year down 5 percent, due to adverse currency effects and divestments

  • 2013 operating income at €958 million (excluding €61 million incidentals: €897 million; 2012: €908 million excluding impairment)

  • Net income attributable to shareholders €724 million (2012: €386 million excluding impairment) and adjusted EPS at €2.62 (2012: €2.55)

  • Net debt down €769 million at €1,529 million (2012: €2,298 million)

  • Total dividend for 2013 proposed at €1.45 (2012: €1.45)

  • Performance improvement program completed one year ahead of schedule; target exceeded with €545 million total savings achieved

  • On track to deliver 2015 targets despite expected continued fragile economic environment and volatile foreign currencies in 2014

Q4 2013 in € million*

Q4 2012

Q4 2013

D%

Revenue

3,673

3,482

(5)

Operating income

36

116

Return on Sales (ROS) %

1.0

3.3

EBITDA

205

208

1

Net income attributable to shareholders

(27)

51

Full-year 2013 in € million*

FY 2012

FY 2013

D%

Revenue

15,390

14,590

(5)

Operating income

908

958

6

- excluding 2013 incidentals

897

(1)

Return on Sales (ROS) %

5.9

6.6

EBITDA

1,597

1,513

(5)

Net income attributable to shareholders

386

724

88

Akzo Nobel N.V. (AkzoNobel) today announced its Q4 and full-year 2013 results. Revenue for the year totaled €14,590 million, down 5 percent on 2012 as a consequence of adverse currency effects and divestments. 2013 operating income excluding incidentals came in at €897 million (2012: €908 million excluding impairment). Net income attributable to shareholders reached €724 million, up from €386 million in 2012. Net debt came down by a third to €1,529 million at the end of 2013. The company has successfully completed its multi-year performance improvement program a year ahead of schedule, exceeding its targets in doing so. In 2014, AkzoNobel will continue to significantly restructure to reduce costs further and anticipates related restructuring charges of at least €250 million.

CEO Ton Büchner
"We indicated at the start of 2013 that trading conditions would continue to be challenging and that has proven to be the case. In response we accelerated our company-wide improvement actions and have brought our performance improvement program to a successful conclusion a year ahead of schedule and above target. While the first half of 2013 was impacted by weaker trading conditions and specific one-off events in Specialty Chemicals, the second half has shown early signs of stabilization in several end markets. In combination with our restructuring actions this positive effect has been evident in our improving return on sales in the third and fourth quarters, despite foreign currency headwinds. In 2014, we will continue to improve our ability to leverage our strong brands and leading market positions. We will further restructure our business, reduce our costs and drive organic growth. I am confident that we are on track to deliver on our 2015 strategic goals."